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Abstract: Cervical cancer is the leading cause of cancer deaths for women worldwide.  Cervical 
screening and early treatment can help to prevent cervical cancers. Cervical screening programs 
in Nepal are often associated with a number of socioeconomic, cultural, and ethical challenges. 
This paper discusses some central ethical challenges in providing cervical cancer screening 
in the Nepalese context and culture. It is necessary to address these challenges for successful 
implementation of such screening programs.
Keywords: public health screening, ethics, women, South Asia
Background
Cervical cancer is one of the most prevalent cancers affecting women globally. The 
worldwide incidence of cervical cancer is approximately 510,000 new cases annually, 
with approximately 288,000 deaths.1 More than 85% of these deaths are reported in 
low and middle income countries.2 The World Health Organization estimates that 
a crude incidence rate of cervical cancer in Nepal is 24.2 per 100,000 women per 
year, with 3,504 new cases diagnosed every year and 1,872 deaths.3 The incidence 
rate of cervical cancer in the neighboring country, India, is reported to be the highest 
in South Central Asia, with an age-standardized incidence rate of 30.7 per 100,000 
and an age-standardized mortality rate of 17.4 per 100,000.4 High cervical cancer 
incidence has also been reported in Eastern and Western Africa, South America, and 
Middle Africa.5
The introduction of different screening techniques for cervical cancer has led to a 
significant reduction in morbidity and mortality from the disease. Screening techniques 
vary with test characteristics, feasibility, and economic considerations. Various screen-
ing techniques have been introduced for early detection of cervical cancer in Nepal. 
For instance, Papanicolaou smear screening (cervical cytology) has been reported to 
be a good method for detecting early cervical cancer.6 Although the Papanicolaou test 
has been used as a primary method of screening in Nepal, feasibility of its introduction 
among the general population is often questioned due to restrictions in the present 
infrastructure and a lack of human and financial resources.6–8 The human papilloma 
virus (HPV) test has been used for identifying high-risk HPV in women’s cervixes 
and gives highly sensitive test results.9 However, the high cost associated with HPV 
testing has affected its use in Nepal and other low resource settings.10 More recently, 
visual inspection after acetic acid application (VIA) has been found to be a most 
promising alternative screening test in Nepal, given that it is convenient, affordable, 
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and accurate.11–13 Cervical screening has been associated with 
a number of socioeconomic, cultural, and ethical challenges 
in Nepal, including social inequalities, violation of autonomy, 
affordability, and acceptability, as well as insufficient and 
inefficient health care resources.14,15 It is necessary to address 
these challenges for successful implementation of screening 
programs and ultimately to have an enduring effect on the 
health of women.
Policy context and challenges  
for Nepal
The coverage rates for cervical cancer screening services is 
very low (2.4%) in Nepal.3 The low coverage may be related 
to a variety of factors, including socioeconomic and cultural 
barriers. Studies have documented poverty, lack of informa-
tion, fear of promiscuity among teenagers, myths, and lack 
of support from husbands and families as major obstacles to 
screening.16 For instance, asymptomatic women are uncon-
cerned with screening.17,18 Due to lack of routine screening, 
women from poor communities often seek care only when 
they develop symptoms, often at an advanced stage of the 
cancer. Sherpa highlighted a lack of knowledge regarding 
the preventive role of screening, lack of time available, and 
permission from husbands to go for cervical cancer screen-
ing as obstacles to screening in Nepal.7 Moreover, lack of 
privacy during screening, embarrassment among women, 
and low importance given to women’s health issues have 
also been cited as factors contributing to the reluctance of 
women to access cervical cancer screening services in low 
income countries.4
The 2010 national guideline for cervical cancer screening 
in Nepal has prioritized prevention of cervical cancer through 
screening and has emphasized using the VIA approach for 
cervical cancer screening.19 The guideline has highlighted the 
need for integration of cervical cancer screening programs 
and prevention through national health policy and repro-
ductive health programs. The integration of cervical cancer 
screening with regular health services could potentially 
increase the uptake of screening services. It has underlined 
the pre- and post- screening counseling to women and their 
family members which may support informed consent and 
increase service utilization. The provision of cervical cancer 
screening through static service sites, as well as mobile 
clinics, may improve access to services for people living 
in rural and remote areas, contributing to equal access to 
the service. The policy has identified primary health care 
centers as the starting point of screening, since they are 
distributed all over the country, and also emphasized the 
referral  system. Although we moved from Papanicolaou to 
VIA, the same set of problems persist. While the government 
made a commitment to reduce cervical cancer by introduction 
of a commendable screening program, there are still chal-
lenges to the implementation of cervical screening policy. 
 Important considerations that need to be taken into account 
are the lack of discussion about various issues with respect to 
rights of clients on equal treatment, respecting their privacy, 
and the right to appropriate treatment, which have not been 
sufficiently explored.
This paper discusses some central ethical challenges in 
providing cervical cancer screening in the Nepalese culture 
and context. These challenges are analyzed using the basic 
principles of public health ethics.
Ethical issues
Cervical cancer screening programs are often associated 
with ethical dilemmas. Various ethical challenges may 
be associated while conducting the VIA test. These may 
include issues of informed consent and privacy of informa-
tion, issues regarding challenges of inequalities and access 
to screening services, along with concerns about benefits 
and harms of screening. With limited health care resources 
and competing health care needs, it is very difficult to fund 
screening programs in low resource settings like Nepal, and 
this may lead to low and unequal uptake of cervical screen-
ing by various subgroups of the population. For successful 
implementation of the screening program, it is essential to 
deal with these issues.
Ethical principles
Public health ethics involve identification, analysis, and reso-
lution of ethical problems arising in public health practice. 
Ethical principles to be followed in public health programs 
are expected mainly to maximize benefits and minimize 
unnecessary harms to participating individuals. Many ethical 
principles are employed in cancer screening, and it is believed 
that focusing on principle-based common morality can help 
to analyze and ethically justify problematic issues with 
regard to outcomes of a public health measure, considering 
the rights of individuals and groups and taking into account 
the characteristics of what constitutes a good society.20 Four 
widely accepted principles that describe the ethical con-
cerns of public health practice are autonomy, beneficence, 
nonmaleficence, and justice.21 Autonomy refers to the duty 
to respect persons and their rights of self-determination. 
Beneficence refers to the obligations to maximize possible 
benefits, whereas nonmaleficence refers to the duty to prevent 
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or do no harm. Justice refers to the duty to treat individuals 
fairly (right to equity).
Common ethical dilemmas  
in cervical cancer screening in Nepal
Ensuring informed consent
Respect for patient autonomy is the ethical principle that 
lies behind informed consent. Informed consent is almost 
a universal phenomenon in health care service. The basic 
requirements of informed consent are that the health care pro-
vider conveys the necessary information to the patient with 
regard to the nature of their illness and respects the patient’s 
decision-making. It is ethically and legally permissible for 
patients with decision-making capacity to refuse unwanted 
medical treatment.
In the context of cervical cancer screening, informed con-
sent demands provision of information about the individual’s 
personal risk of developing cervical cancer, the benefits of 
a screening test, accuracy of the test, further provision of 
treatment if a positive result is detected on screening, as well 
as effective communication. Concerns about communication 
between service provider and patients during screening is 
evident in Nepal.22 It has been reported that nearly 50% of 
Nepalese patients are unable to understand informed consent 
properly due to illiteracy.23 As a result of lack of informa-
tion, women are unable to understand the screening test 
procedure and therefore may not be able to accept the test. 
It is the responsibility of the health care providers to give 
appropriate as well as complete information regarding the 
screening and treatment programs to the patients and fam-
ily in the way that they can understand. This could promote 
acceptance and uptake of the newly launched VIA screening 
test in Nepal.
Woman’s autonomy may be affected by various socio-
logical challenges that exist in Nepalese society. Women 
have less power and autonomy than men in regard to 
making decisions about their own health care.24 Women 
often have to consult their husbands before any treatment 
can be accepted.25 Women’s decision-making processes 
are often affected by their economic situation.24 Women 
of high socioeconomic status in Nepal may pay close 
attention to the lesions detected early and may go for 
immediate treatment, but there may be barriers for women 
from deprived social strata because of lack of material 
resources, such as the cost of transport to the treatment 
center. For these reasons, people of low socioeconomic 
status may delay about knowing their disease status or delay 
treatment in the case they had health problems.26 In these 
circumstances, women’s lack of autonomy regarding health 
care decision-making not only has the potential to affect 
their health, but also reduces their participation in screen-
ing programs.
Privacy of information
Another aspect related to autonomy is privacy of  information. 
The cancer screening consultation is sensitive in nature and 
screening clinics should ensure privacy. It has been reported 
that lack of privacy for women is one of the important rea-
sons behind nonattendance for screening in Nepal.27 Further 
perceived barriers to screening include fear and shame, 
especially in a situation when there is unnecessary exposure 
of the private parts in the presence of male health care provid-
ers.28,29 This may negatively affect trust in women and their 
participation in screening may be affected. Women who chose 
cervical screening in Peru, Kenya, Mexico, and South Africa 
felt that providers should take time to converse with them, 
answer questions, explain procedures, and give encourage-
ment during the screening procedure.30 Women need to feel 
confident that the privacy of their results is  maintained.31 
Indeed, Ghimere et al reported a lack of privacy and confi-
dentiality at government hospitals in Nepal, highlighting the 
lack of this essential component in the provision of health 
care.32 The notion of limited privacy extends beyond Nepal, 
with women in Nigeria also highlighting this as their main 
reason for nonparticipation in cervical cancer screening 
programs.33 Like other screening tests, the VIA test has to 
be performed with an intimate examination. It is essential 
that the health care provider gains the trust of the woman, 
addresses her concerns, and initiates a meaningful dialog 
with her to ensure consent. Sex preferences of attending 
medical personnel may also affect attendance. Intensive and 
appropriate training of health care providers would help to 
develop an emotional connection with regard to the issues of 
patient privacy and patients’ rights to control information.34 
Further, the national guideline should highlight policies that 
govern patient privacy.
Benefits of screening
The benefits of implementing a VIA screening program in 
all the primary health care centers of Nepal are obvious. 
These may include early treatment for cancer, prevention of 
cervical cancer, alleviation of suffering, and being accessible 
to women. In addition, the test has minimal complications, 
produces instant results, and health care providers, after 
intensive training and supervision, can safely provide testing 
and treatment in primary care settings.34 In low resource 
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settings, screening with the VIA test has been considered to 
be the most feasible and practical approach for early detection 
of cervical cancer, and is the most effective in, for instance, 
reducing the burden of disease at an affordable cost.35–37 
Ethically, providing VIA as an alternative to other high-cost 
screening programs for prevention of cervical cancer in a 
low resource setting is a significant and reasonable act of 
beneficence.
Health care providers are expected not to cause harm, 
and have an obligation to help their patients. The goal of 
public health should be to promote the welfare of patients, 
and health providers should possess skills and knowledge that 
enable them to assist others. The success of any health care 
practice relies on the professional behavior of the attending 
health care professional. However, health care providers will 
always encounter ethical issues and these need to be carefully 
addressed with all patients. Previous studies have identified 
challenges to the health care provider–patient relationship 
as including fear of malpractice and lack of knowledge, as 
well as the shortage of skilled health workers while screening 
for cervical cancer.38 It is therefore essential for health care 
providers to be appropriately trained and qualified so that 
they deliver the sensitive care required when women choose 
to attend for cervical screening.31
Risks of screening
In addition to beneficence, it is important to be aware that 
an organized screening program not only achieves a net 
health benefit for a community, but can also result in adverse 
 outcomes. VIA screening, like all public health screening, can 
have false-positive results.39 A false-positive result means that 
women without the disease are incorrectly identified as being 
at risk, and subsequently undergo follow-up testing that may 
be uncomfortable, expensive, and, in some cases, potentially 
harmful, and some may even receive unnecessary treatment. 
The patient and their family may suffer from psychological 
consequences, such as distress and anxiety.40 Generally, the 
better the test and the training of the people administering 
and interpreting the test, the lower the risk of a false-positive 
result. At this stage, the health care provider must consider 
his or her duty not to harm the patient and weigh the psy-
chological risks of inviting the patient for screening against 
the physical risks of not doing so. In this case, the risks of 
generating psychological damage seem comparatively great 
and the chance of doing good seems comparatively small. 
Perhaps one way to establish a balance is to ensure that the 
benefit of screening is maximized and the risk is minimized. 
One of the crucial ways of reducing anxiety is to ensure that 
before, during, and after the screening process the patient 
is fully informed and thus involved in the decision-making 
process; also, the potential concerns of women need to be 
addressed in a respectful way. It is therefore ethically impera-
tive that the health care provider performing the VIA test 
attend to these details.
A further inherent risk of screening is the occurrence 
of false-negative results. This epidemiological term refers 
to people being tested and wrongly identified as without 
risk, but in reality living with an increased risk of a disease. 
Such a result can give false reassurance. Under the prin-
ciple of nonmaleficence (doing no harm), it is important 
to reduce the chance of this happening. In public health 
terms, false-positives and false-negatives are related to 
the quality of the test, referred to as the sensitivity and 
specificity of the test.41
The acceptability of screening may be limited by personal 
beliefs, fatalism, or fear. Women may fear that a cervical 
cancer diagnosis would bring them shame, blame, and 
even abandonment by their husbands and families, so some 
may prefer not to know because of their fear of a positive 
result.4,42 Further, women in Nepal’s patriarchal society may 
fear the stigma associated with a test result; for example, 
they may worry about male partners suspecting them of 
having a sexually transmitted infection. Stigma, as defined 
by Goffman, involves rejection of an individual with an 
attribute that is deeply discredited by society as a result of 
the attribute.43 Developing culturally appropriate messages 
and educational materials and identifying effective factors 
may help to encourage women to participate in cervical 
cancer screening and may decrease the stigma of treatment. 
Obviously, such health promotion messages also need to 
be aimed at men to help reduce the stigma experienced by 
women. In addition, the significant issues associated with 
stigma need careful consideration while developing cervical 
cancer screening for Nepalese women. In the case of VIA 
inspection, access to information (benefits and risks) can 
motivate both patients and their families to be proactive in 
health care decision-making.
Social inequalities
Cervical cancer and other sexually transmitted infections 
can occur in people regardless of age, sex and other factors. 
Since most of the disparities in disease burden are rooted 
in inequitable access to health care, it would be against the 
principle of justice to provide health care to one group and 
hold back health care from another group because of bias to 
do with age, sex or other factors.44 Justice denotes fair and 
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equitable treatment, and the principle of justice implies that 
a screening program should be available to all who need it. 
A study revealed that the urban population in Nepal, with 
its high literacy rate and access to treatment, benefits more 
from screening programs (coverage 4.7%) than the rural 
population of Nepal (coverage 2%).3 It is the women from 
poor households, rural areas, and regions with low health 
care expenditure who are reported to have difficulty utilizing 
cervical cancer screening.45,46 Nygård et al found that nonat-
tendance for cervical screening was associated with economic 
barriers.47 Based on all these facts, VIA screening is likely to 
create health disparities because there are still issues regarding 
how poor, underserved, and hard-to-reach women access this 
service. For justice to be served, the screening service should 
be made available at a reduced cost to those who are in need, 
irrespective of place of residence and economic status.
Conclusion
Cervical cancer is an important public health problem in low 
income countries, where over 85% of the global deaths occur 
annually. Cervical screening and early treatment are vital to 
help prevent cervical cancers. Cervical screening may possess 
several ethical challenges that need to be addressed through 
careful analysis and consultation with involvement of the 
populations affected. A cost analysis of the most effective 
method of screening, in conjunction with acceptance of that 
method for a given population, is an essential component of 
cervical screening delivery in low income countries. The VIA 
test, being simple, accurate, and cost-effective, can help to 
decrease the persistent gap in health care access in Nepal. 
This requires a strong foundation before its introduction at 
the community level. There should be provision of adequate 
screening information regarding privacy and the rights of 
clients to equal treatment, as well as an accessible and afford-
able service. Barriers need to be identified in the early phase 
so that the necessary steps can be taken towards addressing 
them. If ethical issues are addressed, screening for cervical 
cancer has the potential to improve the health of our nation 
in terms of higher rates of detection of cervical cancer, and 
will become a significant achievement in public health in 
low resource settings.
Disclosure
The authors report no conflicts of interest in this work.
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